PART C
Confirmation format for serious adverse reactions
PART D
Annual notification format for serious adverse reactions
This Table refers to [ ] Whole blood [ ] Red blood cells [ ] Platelets [ ] Plasma [ ] Other (use separate table for each component) |
Number of units issued (total number of units issued with a given number of blood components) |
||||||
Number of recipients transfused (total number of recipients transfused with a given number of blood components) (if available) |
|||||||
Number of units transfused (the total number of blood components (units) transfused over the reporting period) (if available) |
|||||||
|
Total number reported |
Number of serious adverse reactions with imputability level 0 to 3 after confirmation (see Annex IIA) |
|||||
|
Number of deaths |
||||||
|
not assessable |
Level 0 |
Level 1 |
Level 2 |
Level 3 |
||
Immunological Haemolysis |
Due to ABO incompatibility |
Total |
|
|
|
|
|
Deaths |
|
|
|
|
|
||
Due to other allo-antibody |
Total |
|
|
|
|
|
|
Deaths |
|
|
|
|
|
||
Non-immunological haemolysis |
Total |
|
|
|
|
|
|
Deaths |
|
|
|
|
|
||
Transfusion-transmitted bacterial infection |
Total |
|
|
|
|
|
|
Deaths |
|
|
|
|
|
||
Anaphylaxis/hypersensitivity |
Total |
|
|
|
|
|
|
Deaths |
|
|
|
|
|
||
Transfusion related acute lung injury |
Total |
|
|
|
|
|
|
Deaths |
|
|
|
|
|
||
Transfusion-transmitted viral Infection |
HBV |
Total |
|
|
|
|
|
Deaths |
|
|
|
|
|
||
HCV |
Total |
|
|
|
|
|
|
Deaths |
|
|
|
|
|
||
HIV-1/2 |
Total |
|
|
|
|
|
|
Deaths |
|
|
|
|
|
||
Other (specify) |
Total |
|
|
|
|
|
|
Deaths |
|
|
|
|
|
||
Transfusion-transmitted parasitical infection |
Malaria |
Total |
|
|
|
|
|
Deaths |
|
|
|
|
|
||
Other (specify) |
Total |
|
|
|
|
|
|
Deaths |
|
|
|
|
|
||
Post-transfusion purpura |
Total |
|
|
|
|
|
|
Deaths |
|
|
|
|
|
||
Graft versus host disease |
Total |
|
|
|
|
|
|
Deaths |
|
|
|
|
|
||
Other serious reactions (specify) |
Total |
|
|
|
|
|
|
Deaths |
|
|
|
|
|